Drug Discovery Technology Alert. Harnessing Cellular Senescence Pathway for Cancer Therapeutics; Biomarker Discovery and Drug Profiling Empowered by Label-Free Phosphoproteomics; Fragment-Based Discovery Being Explored for Ras Gene-Targeting Drugs
This issue profiles harnessing cellular senescence pathway for cancer therapeutics, biomarker discovery and drug profiling empowered by label-free phosphoproteomics, and a drug composition as therapeutic/vaccine for obesity and atherosclerosis.
Click headings to expand and collapse
Published: 13 Jan 2012
Tools
Features of this research
Help Desk
For more information and general enquiries, contact Frost & Sullivan near you.
Select a location near you..